Table of Contents Table of Contents
Previous Page  982 / 1851 Next Page
Information
Show Menu
Previous Page 982 / 1851 Next Page
Page Background

ChemoRT Induction

Cisplatin 50 mg/m

2

d 1,8,29,36

Etoposide 50 mg/m

2

IV d 1-5 & 29-33

Concurrent RT 59.4 Gy (1.8 Gy/fr)

CR, PR, or SD;

ECOG PS 0-2

Docetaxel 75 mg/m

2

q 3 wk

3

Observation

Randomize

Consolidative Docetaxel after Concurrent CT-RT:

Hoosier Oncology Group (HOG LUN 01-24)

Hanna N, et al.

J Clin Oncol.

2008;26